Erratum: IL-1 family nomenclature

Abstract

In the version of this article initially published, some of the text on p 882 was inaccurate. The correct text should read as follows: "thereby counteracting the beneficial effects of blocking IAPP on islet inflammation" (middle column) and "This mechanism has been suggested to mediate ROSdependent inflammasome activation induced by high concentrations of glucose in mouse pancreatic beta cells 12 , although this finding is now being debated" (right column, first full paragraph, second sentence). The errors have been corrected in the HTML and PDF versions of the article. In the version of this article initially published, the actin loading control in Figure 6b (left) was incorrect. The correct figure is provided here. The error has been corrected in the HTML and PDF versions of the article. e r r ata a n d c o r r i g e n d a

IL-36R ligands are potent regulators of dendritic and T cells

“…In addition, IL-1F5, which has been shown to exert receptor antagonist activities, has been renamed IL-36Ra. 15 Currently, little is known regarding the expression pattern and the biologic function of IL-36␣, IL-36␤, and IL-36␥. Messenger RNAs for these cytokines are highly expressed in only a few tissues, particularly in internal epithelial tissues, which are exposed to pathogens and in skin.…”